Document is current
Any future updates will be listed below
-
Authors
Fennell, Katie A.
Vassiliadis, Dane https://orcid.org/0000-0002-7814-4851
Lam, Enid Y. N. https://orcid.org/0000-0001-5843-7836
Martelotto, Luciano G.
Balic, Jesse J.
Hollizeck, Sebastian https://orcid.org/0000-0002-9504-3497
Weber, Tom S.
Semple, Timothy
Wang, Qing
Miles, Denise C.
MacPherson, Laura
Chan, Yih-Chih https://orcid.org/0000-0003-2177-5406
Guirguis, Andrew A. https://orcid.org/0000-0003-3134-0596
Kats, Lev M. https://orcid.org/0000-0001-8742-8138
Wong, Emily S. https://orcid.org/0000-0003-0315-2942
Dawson, Sarah-Jane https://orcid.org/0000-0002-8276-0374
Naik, Shalin H. https://orcid.org/0000-0003-0299-3301
Dawson, Mark A. https://orcid.org/0000-0002-5464-5029
- License Information
-
More Information
Article History
Received: 9 November 2020
Accepted: 30 October 2021
First Online: 8 December 2021
Competing interests
: M.A.D. has been a member of advisory boards for CTX CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix. S.-J.D. has been a member of advisory boards for AstraZeneca. S.-J.D. has received research funding from Genentech. M.A.D. and S.-J.D. receive research funding from CTx CRC. The other authors declare no competing interests.
